万邦医药 (301520.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(万邦医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度
上市前/上市后 上市后上市后上市后上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 90,172,342.02101,152,904.8075,661,205.4392,933,998.9872,058,423.6480,418,859.1872,723,218.04
 营业收入(元) 90,172,342.02101,152,904.8075,661,205.4392,933,998.9872,058,423.6480,418,859.1872,723,218.04
二、营业总成本(元) 65,349,751.6771,286,155.5254,900,456.5860,366,121.7444,258,960.4748,323,729.3442,682,978.61
 营业成本(元) 47,825,532.4957,406,962.4937,441,467.5745,667,321.0234,018,050.4440,743,117.4434,180,758.15
 研发费用(元) 10,738,916.3910,628,336.2111,201,833.537,766,110.194,924,815.493,928,843.493,929,132.90
 营业税金及附加(元) 369,055.88391,209.38366,067.59244,708.31158,796.43154,749.37276,987.62
 销售费用(元) 939,770.05748,125.70674,981.221,791,331.991,321,632.25942,089.241,229,296.56
 管理费用(元) 6,809,525.676,386,732.385,378,169.025,032,350.833,877,474.832,928,343.543,248,955.37
 财务费用(元) -1,333,048.81-4,275,210.64-162,062.35-135,700.60-41,808.97-373,413.74-182,151.99
  其中:利息费用(元) ----115.79460.49801.21
  其中:利息收入(元) 1,338,763.354,280,223.44164,127.15137,328.3248,949.72377,707.86185,312.94
 资产减值损失(元) -448,901.30116,824.74-604,784.03-652,388.90-313,732.11-4,635.95-316,031.71
 信用减值损失(元) -103,996.54-1,507,745.31324,859.65-1,336,753.50-133,496.60-861,060.76-207,144.44
三、其他经营收益
 加:公允价值变动收益(元) 6,879,458.322,927,999.99-----
 加:投资收益(元) 679,300.01425,783.66271,229.10923,012.47813,019.17747,730.72859,944.74
 其他收益(元) 299,034.551,601,672.273,483,985.13474,474.25339,125.83-2,109,070.307,342,777.21
四、营业利润(元) 32,127,485.3933,431,284.6325,094,288.6931,976,221.5628,504,379.4629,868,093.5537,719,785.23
 加:营业外收入(元) 291,700.00289,012.46147,942.38284,347.0336,284.462,877,297.00-
 减:营业外支出(元) 43,418.6218,743.39109.00-100,000.00-3,520.80
五、利润总额(元) 32,375,766.7733,701,553.7025,242,122.0732,260,568.5928,440,663.9232,745,390.5537,716,264.43
 减:所得税费用(元) 2,688,682.512,921,168.921,751,216.023,427,188.323,453,485.712,937,654.744,615,566.46
六、净利润(元) 29,687,084.2630,780,384.7823,490,906.0528,833,380.2724,987,178.2129,807,735.8133,100,697.97
(一)按经营持续性分类
  持续经营净利润(元) 29,687,084.2630,780,384.7823,490,906.0528,833,380.2724,987,178.2129,807,735.8133,100,697.97
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 29,687,084.2630,780,384.7823,490,906.0528,833,380.2724,987,178.2129,807,735.8133,100,697.97
 扣除非经常性损益后的净利润(元) 22,744,459.4626,865,477.5019,419,187.9127,366,000.0024,044,500.0028,509,000.0026,111,200.00
七、每股收益
 一、基本每股收益(元) 0.450.450.470.580.500.590.66
 二、稀释每股收益(元) 0.450.45--0.500.59-
九、综合收益总额(元) 29,687,084.2630,780,384.7823,490,906.0528,833,380.2724,987,178.2129,807,735.8133,100,697.97
 归属于母公司所有者的综合收益总额(元) 29,687,084.2630,780,384.7823,490,906.0528,833,380.2724,987,178.2129,807,735.8133,100,697.97
公告日期 2024-04-202024-04-202023-10-252023-09-052024-04-202023-05-262023-10-25
审计意见(境内) 标准无保留意见标准无保留意见

前瞻产业研究院